Iron Dextran Injection market is entering a phase of consistent expansion, reaching USD 5,085 million in 2024 and projected to climb to USD 6,940 million by 2031, registering a CAGR of 4.7%. The growth trajectory reflects increasing awareness of iron deficiency anemia across human and veterinary segments, coupled with rising clinical demand for safe, effective, and rapid parenteral ir... https://www.24lifesciences.com/iron-dextran-injection-market-market-3095